Selection of plasma donors for the production of anti-SARS-CoV-2 immunoglobulin-based therapies: Strategies for quantitative antibody measurements-Reference-Cited by-同舟云学术

Selection of plasma donors for the production of anti-SARS-CoV-2 immunoglobulin-based therapies: Strategies for quantitative antibody measurements

Published:2022-12 Issue:6 Volume:61 Page:103513
ISSN:1473-0502
Container-title:Transfusion and Apheresis Science
language:en
Short-container-title:Transfusion and Apheresis Science

Author:

Benites Bruno Deltreggia,Costa-Lima Carolina,Pinto Fernanda Batista Rosa,da Costa Vitor Antonio,Duarte Adriana da Silva Santos,Zangirolami Audrey Basso,Amaro Emerson Clayton,Granja Fabiana,Proenca-Modena José Luiz,Saad Sara Terezinha Olalla,Addas-Carvalho Marcelo

Funder

Conselho Nacional de Desenvolvimento Científico e Tecnológico

FAEPEX

Publisher

Elsevier BV

Subject

Hematology

Reference25 articles.

1. Recent updates in experimental research and clinical evaluation on drugs for COVID-19 treatment;Zou;Front Pharm,2021

2. Virology, epidemiology, pathogenesis, and control of COVID-19;Jin;Viruses,2020

3. Effect of high-titer convalescent plasma on progression to severe respiratory failure or death in hospitalized patients with COVID-19 pneumonia: a randomized clinical trial;Menichetti;JAMA Netw Open,2021

4. Association between convalescent plasma treatment and mortality in COVID-19: a collaborative systematic review and meta-analysis of randomized clinical trials;Axfors;BMC Infect Dis,2021

5. Clinical application of antibody immunity against SARS-CoV-2: comprehensive review on immunoassay and immunotherapy;Cheng;Clin Rev Allergy Immunol,2022

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Utilization of the Abbott SARS-CoV-2 IgG II Quant Assay To Identify High-Titer Anti-SARS-CoV-2 Neutralizing Plasma against Wild-Type and Variant SARS-CoV-2 Viruses;Microbiology Spectrum;2022-10-26